HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects-Reference-Cited by-同舟云学术

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Published:2010-03-14 Issue:4 Volume:16 Page:460-465
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

J Buzón Maria,Massanella Marta,Llibre Josep M,Esteve Anna,Dahl Viktor,Puertas Maria C,Gatell Josep M,Domingo Pere,Paredes Roger,Sharkey Mark,Palmer Sarah,Stevenson Mario,Clotet Bonaventura,Blanco Julià,Martinez-Picado Javier

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2111.pdf

Reference32 articles.

1. Davey, R.T. Jr. et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. USA 96, 15109–15114 (1999).

2. Markowitz, M. et al. Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J. Infect. Dis. 186, 634–643 (2002).

3. Jiang, W. et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199, 1177–1185 (2009).

4. Middleton, T. et al. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. Antiviral Res. 64, 35–45 (2004).

5. Svarovskaia, E.S. et al. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J. Virol. 78, 3210–3222 (2004).

Cited by 463 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological Effects of Integrase Inhibitors as Part of Initial Therapy in People Living with HIV: A Systematic Literature Review;IATREIA;2024

2. The cell biology of HIV-1 latency and rebound;Retrovirology;2024-04-05

3. Biocompatible metal–organic frameworks as promising platforms to eradicate HIV reservoirs ex vivo in people living with HIV;Journal of Materials Chemistry B;2024

4. Efectos inmunológicos de los inhibidores de integrasa versus inhibidores de la proteasa y de la transcriptasa reversa no nucleótidos como parte de la terapia de inicio en personas viviendo con VIH. Una revisión sistemática de la literatura;Iatreia;2024

5. Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure;Current HIV/AIDS Reports;2023-11-13